For prescribers managing pelvic-floor and localized muscle conditions, combination baclofen and diazepam suppositories are a recognized compounded option. Mixwell Compounding Pharmacy in Chino, CA prepares these preparations to each prescriber's exact specifications, using PCCA base technology selected to support the intended route of delivery.
🔬 What Are Baclofen & Diazepam Suppositories?
Baclofen is a muscle relaxant that acts on GABA-B receptors. Diazepam is a benzodiazepine that acts on GABA-A receptors. Both are agents that prescribers have used in the management of muscle-related conditions. When compounded together into a suppository, they are formulated for localized delivery to the pelvic-floor region.
Because commercial products don't offer this specific combination or dosage form, a compounded suppository is prepared individually when a prescriber determines it is appropriate for a patient.
💧 Why a Suppository? Route Considerations
These active ingredients can be delivered by more than one route. For pelvic-floor applications, prescribers frequently prefer a suppository — vaginal or rectal — because it places the preparation near the target musculature and is associated with lower systemic exposure than equivalent oral administration. The prescriber determines the route, strength, and combination appropriate for each patient.
Localized delivery
Formulated to place actives near the pelvic-floor musculature.
Route flexibility
Vaginal or rectal suppository, as specified by the prescriber.
Custom combinations
Baclofen and diazepam together — or with additional actives — as prescribed.
Tailored formulation
Dye-, filler-, or preservative considerations addressed on request.
🧴 PCCA Base Technology for Suppositories
The base influences how a suppository releases its active ingredients and how it performs for the patient. Mixwell selects PCCA base technology to match the prescriber's intended release profile and route.
💎 Base Selection Matched to the Goal
🌷 MucoLox™ — Mucoadhesive
A mucoadhesive base designed to adhere to mucosal tissue, supporting retention for preparations intended for localized mucosal delivery.
🧊 Suppository base options
PCCA fatty and water-soluble suppository base technology allows selection of a release profile suited to the formulation.
🧬 Multi-active capable
Bases that can accommodate more than one active ingredient in a single preparation, as prescribed.
✨ Consistent preparation
Prepared under quality standards for a uniform, well-formed finished suppository.
❓ What is a mucoadhesive base?
A mucoadhesive base is a compounding vehicle designed to adhere to mucosal tissue after application. In preparations intended for localized mucosal delivery, this property supports retention at the site of application, which can be a consideration for prescribers formulating suppositories.
⭐ Why Prescribers Choose Compounded Suppositories
🩺 For Prescribers
- Specify the exact combination, strengths, and route
- Choose a base matched to your intended release profile
- Request formulations that aren't commercially manufactured
- Order additional actives in one preparation as clinically directed
🌿 For Patients
- A preparation made specifically to their prescription
- A localized route as directed by their prescriber
- Prepared by a licensed compounding pharmacy team
- Clear instructions provided on the prescription label
📚 Clinical Context for Prescribers
🚀 How to Send a Prescription
- Specify the actives, strengths, route (vaginal or rectal), base preference, and quantity on your prescription.
- Fax or e-prescribe to Mixwell Compounding Pharmacy in Chino, CA, following controlled-substance requirements for the diazepam component.
- Call (909) 378-7301 to confirm the formulation and current turnaround time.
- Your patient picks up at our Chino pharmacy, or we can deliver — we serve patients across California.
❓ Frequently Asked Questions
Is a prescription required, and is diazepam controlled?
Yes. A valid prescription from a licensed prescriber is required. Diazepam is a Schedule IV controlled substance, so controlled-substance prescribing requirements apply to the diazepam component.
Why is a suppository used instead of an oral form?
For pelvic-floor applications, prescribers frequently prefer a suppository because it places the preparation near the target musculature and is associated with lower systemic exposure than equivalent oral administration. The prescriber determines the appropriate route.
What base does Mixwell use for these suppositories?
We select PCCA base technology to match the prescriber's intended release profile and route — for example, a mucoadhesive base such as MucoLox™ for retention, or a fatty or water-soluble suppository base. The prescriber may specify a preference, or we can advise.
Can additional actives be combined in the same suppository?
Depending on compatibility, additional actives can be included in a single preparation when specified by the prescriber. Our pharmacists review each prescription for formulation suitability.
Are these preparations FDA-approved?
No. Compounded preparations are not FDA-approved and are prepared individually pursuant to a valid prescription.
Does Mixwell accept insurance?
Mixwell does not accept insurance. Call (909) 378-7301 for current pricing.
Partner With Mixwell for Custom Suppository Formulations
Mixwell Compounding Pharmacy
13788 Roswell Ave, Ste 158 · Chino, CA 91710
PCCA Member · CA Licensed · USP <795> · Non-Sterile Compounding · Delivery Across California
📞 Call (909) 378-7301References: Crisp CC, Vaccaro CM, Estanol MV, Oakley SH, Kleeman SD, Fellner AN, Pauls RN. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24(11):1915-1923. (PMID 23681047) | Holland MA, Joyce JS, Brennaman LM, Drobnis EZ, Starr JA, Foster RT Sr. Intravaginal diazepam for the treatment of pelvic floor hypertonic disorder: a double-blind, randomized, placebo-controlled trial. Female Pelvic Med Reconstr Surg. 2019;25(1):76-81. (PMID 29280763) | Note: available randomized trials of intravaginal diazepam did not demonstrate superiority over placebo; the evidence base is limited and mixed, and use remains at the prescriber's clinical discretion. | Foundational pharmacology of baclofen (GABA-B) and diazepam (GABA-A) per standard clinical references. | MucoLox™ is a mucoadhesive compounding base from PCCA; base characteristics per manufacturer technical documentation. | Educational information for licensed prescribers; not a substitute for clinical judgment. Reviewed by Mixwell Compounding Pharmacy compounding team, Chino, CA.